Evofem Biosciences, Inc. (EVFM): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-15, first reflected in a filing dated 2022-05-10. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

6.42B
Year ended 2025-12-31
2020-12-31: 67.16M2021-12-31: 8.73M2022-12-31: 466.0K2023-12-31: 984.04M2024-12-31: 80.00M2025-12-31: 6.42B6.42B
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-316.42Bn/m2026-03-11, From 2025-01-01
2024-12-3180.00Mn/c2026-03-11, From 2024-01-01
2023-12-31984.04Mn/m2025-03-24, From 2023-01-01
2022-12-31466.0K-94.7%2024-03-27, From 2022-01-01
2021-12-318.73Mn/c2023-04-27, From 2021-01-01
2020-12-3167.16Mn/a2022-03-10, From 2020-01-01